Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definitions
1.2 Research design
1.2.1 Research approach
1.2.2 Data collection methods
1.3 Base estimates & calculations
1.3.1 Base year calculation
1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
1.5.1 Primary sources
1.5.2 Data mining sources
Chapter 2 Executive Summary
2.1 Industry 3600 synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Rising research & development activities for animal healthcare
3.2.1.2 Frequent FMD outbreaks
3.2.1.3 Government initiatives and regulations
3.2.2 Industry pitfalls & challenges
3.2.2.1 Stringent regulatory scenario
3.3 Growth potential analysis
3.4 Reimbursement scenario
3.5 Regulatory landscape
3.6 Technological landscape
3.7 New emerging therapies
3.8 Porter's analysis
3.9 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company matrix analysis
4.3 Competitive analysis of major market players
4.4 Competitive positioning matrix
4.5 Strategy dashboard
Chapter 5 Market Estimates and Forecast, By Vaccine Type, 2021 – 2032 ($ Mn)
5.1 Key trends
5.2 Conventional vaccines
5.2.1 Aluminium hydroxide & saponin-based vaccines
5.2.2 Oil-based vaccines
5.3 Emergency vaccines
Chapter 6 Market Estimates and Forecast, By Animal Type, 2021 – 2032 ($ Mn)
6.1 Key trends
6.2 Cattle
6.3 Sheep & Goat
6.4 Pig
6.5 Other animals
Chapter 7 Market Estimates and Forecast, By Distribution Channel, 2021 – 2032 ($ Mn)
7.1 Key trends
7.2 Veterinary hospitals & clinics
7.3 Government institutions
7.4 Retail pharmacies
7.5 Online pharmacies
Chapter 8 Market Estimates and Forecast, By Region, 2021 – 2032 ($ Mn)
8.1 Key trends
8.2 North America
8.2.1 U.S.
8.2.2 Canada
8.3 Europe
8.3.1 Germany
8.3.2 UK
8.3.3 France
8.3.4 Spain
8.3.5 Italy
8.3.6 Netherlands
8.3.7 Rest of Europe
8.4 Asia Pacific
8.4.1 China
8.4.2 Japan
8.4.3 India
8.4.4 Australia
8.4.5 South Korea
8.4.6 Rest of Asia Pacific
8.5 Latin America
8.5.1 Brazil
8.5.2 Mexico
8.5.3 Argentina
8.5.4 Rest of Latin America
8.6 Middle East and Africa
8.6.1 South Africa
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Rest of Middle East and Africa
Chapter 9 Company Profiles
9.1 Biogénesis Bagó
9.2 Biovet Private Ltd
9.3 Brilliant Bio Pharma Private Limited
9.4 BVI
9.5 C.H. Boehringer Sohn AG & Co. KG
9.6 Ceva Santé Animale
9.7 Indian Immunologicals Ltd.
9.8 Inner Mongolia Biwei Antai Biotechnology Co., Ltd.
9.9 Kenya Veterinary Vaccines Production Institute
9.10 Merck & Co., Inc.
9.11 MEVAC
